Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Annovis Bio Inc ANVS

Healthcare Biotechnology
Annovis Bio, Inc. is a clinical-stage drug platform company addressing neurodegeneration such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and other chronic neurodegenerative diseases. The Company is developing its lead product candidate, Buntanetap, which is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Buntanetap is a synthetically produced... see more

Recent & Breaking News (NYSE:ANVS)

INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile September 8, 2021

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Annovis Bio, Inc. (ANVS) Investors

PR Newswire September 7, 2021

INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile September 7, 2021

CLASS ACTION UPDATE for DIDI, KPLT and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 6, 2021

SHAREHOLDER ALERT: ATVI ITRM ANVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire September 6, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of QFIN, ATVI and ANVS

Accesswire September 6, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLCT, ANVS and VIEW

Accesswire September 5, 2021

SHAREHOLDER ALERT: BZ PHG ANVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire September 5, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Annovis Bio, Inc. - ANVS

PR Newswire September 5, 2021

ANVS LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Annovis Bio, Inc.

Newsfile September 3, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SLQT, ANVS and SPPI

Accesswire September 3, 2021

ANVS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 18, 2021 in the Class Action Filed on Behalf of Annovis Bio, Inc. Limited Shareholders

Newsfile September 3, 2021

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile September 3, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ANVS, VIEW and HYRE

Accesswire September 3, 2021

CLASS ACTION UPDATE for SRAC, LIVE and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire September 3, 2021

Annovis Bio Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

Newsfile September 3, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Annovis Bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 18, 2021 - ANVS

Newsfile September 2, 2021

SHAREHOLDER ALERT: JRVR BLCT ANVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Accesswire September 2, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Annovis Bio, Inc. - ANVS

Newsfile September 2, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YMM, DIDI and ANVS

Accesswire September 2, 2021